Karin Andersson, M.D., M.P.H. recently completed her Master of Public Health in the Department of Population and International Health at the Harvard School of Public Health, and is a gastroenterology fellow at Massachusetts General Hospital. Her clinical and research interests include viral hepatitis and cost-effective management of disease. Ongoing research projects include evaluating the cost-effectiveness of screening for liver cancer, and, through recent funding from Bristol-Myers Squibb, a cost-effectiveness analysis of the optimal first-line therapy for chronic hepatitis B infection.
Mireia
Diaz-Sanchis is currently a Research
Fellow in the Program in Health Decision Science, funded through a grant from the Bill & Melinda
Gates Foundation. She has been involved in cancer research since
1994. Her research, conducted at the Catalan Institute of Oncology (ICO) in Barcelona, Spain,
focuses on the environmental risk factors in several countries that lead cervical cancer to
develop. She has analyzed case-control studies of cervical cancer conducted in
several countries by the International
Agency for Research on Cancer. She has also conducted research with
epidemiology of liver cancer and multi-country cancer registries. Ms. Diaz-Sanchis graduated with an
M.S. in Statistical Sciences and Techniques from Universitat Politecnica de
Catalunya (UPC), Spain.
Delphine Hu, M.D., MPH is a research associate currently
focused on developing and applying a model of maternal morbidity and mortality
funded by the MacArthur Foundation, as well as exploring the impact of
including male vaccination in a United States-based HPV vaccination screening
program. Her previous work includes
developing the policy model used to assess chlamydia
screening policy and treatment protocols. Her other research interests include
applying mathematical modeling to the cost-effectiveness of cancer treatment
policies as well as the study of "value of Information" to decision making. She received her Masters Degree in Health
Policy and Management (2002) at HSPH and was awarded the AHRQ Fellowship
thereafter (2002-2004).
Amy Knudsen, Ph.D., is a post-doctoral fellow in the Program on Cancer Outcomes Research Training (PCORT) at the Institute for Technology Assessment. She received a B.S. with distinction in Policy Analysis from Cornell University and a Ph.D. in Health Policy from Harvard University. While at Harvard, Amy received a Cancer Prevention Training Grant from the National Cancer Institute and a Dissertation Completion Fellowship from Harvard University. She has also worked for a health-economics consulting firm where she developed decision-analytic models to analyze the lifetime health and economic consequences of obesity, as well as the cost-effectiveness of weight loss agents, of psychotropic medications, and of anti-emetics. Amy is currently developing a population-based colorectal cancer policy model that will be used to explain secular trends in colorectal cancer incidence and mortality and predict future trends under alternative scenarios regarding risk factors for the disease, rates of colorectal cancer screening, and the dissemination of treatment for diagnosed cancer.
Jennifer M. Yeh is post-doctoral research fellow with the NCI-funded Cancer Prevention Program at the Harvard School of Public Health and Dana Farber Cancer Institute. Her research interests focus on using mathematical modeling methods to evaluate the public health and economic impacts of cancer prevention and treatment programs. She graduated from the University of Colorado at Boulder in 1996 with a B.A. in Biology, received an M.S. in Health Policy and Management from the Harvard School of Public Health in 2001, and in 2007 received her doctorate from the Health Policy PhD program at Harvard University, concentrating in Decision Sciences. Before returning to school to pursue her doctorate, she also worked at Abt Associates Inc. where she designed and conducted a variety of economic and quality of life studies in the Clinical Trials Department.